Researchers at IBEC help identifying a drug in clinical phase that blocks the effects of SARS-Co-V2

May 20, 2020April 2, 2020

Researchers at IBEC help identifying a drug in clinical phase that blocks the effects of SARS-Co-V2

IBEC researchers led by ICREA Research Professor Núria Montserrat, together with international collaborators, have identified a drug capable of blocking the effects of the SARS-Co-V2 virus, the origin of the Coronavirus 2019 disease.

The treatment, which can be tested on two hundred Covid-19 patients as of today, has proven effective in mini-kidneys generated from human stem cells. Using hese organoids generated by bioengineering techniques, it has been deciphered how SARS-Co-V2 interacts and infects human kidney cells.

March 24, 2020

IBEC researchers contribute to an international study to regenerate infarcted hearts

Within the EU project BRAVƎ, experts at Institute for Bioengineering of Catalonia (IBEC) combine cell therapy and bioengineering to design a biological device that recovers cardiac functionality in people with cardiovascular diseases.

Researchers at IBEC led by the ICREA Professor Núria Montserrat contribute to the EU project BRAVƎ, an initiative for cardiac regeneration that combines cell therapy and bioengineering to design a biological device capable of recovering cardiac functionality in people with coronary heart disease.

March 23, 2020March 20, 2020

IBEC participates in an international study to stop coronavirus contagion

Researchers at the Institute of Bioengineering of Catalonia (IBEC) led by Professor ICREA Núria Montserrat are studying the role of the receptor ‘Angiotensin converting enzyme’ (ACE2), one of the pathways that the SARS-Co-V2 virus uses to enter our body.

To do this, experts use mini-kidneys, as well as other cell cultures such as cardiac organoids. The goal is to exploit these mini-organs to better understand how the virus works.

February 12, 2021March 16, 2020

IBEC joins the BASE3D community to contribute to the future of 3D printing

The Institute for Bioengineering of Catalonia (IBEC) will contribute its extensive experience in 3D printing and bioprinting to the BASE 3D community, an entity that brings together research centers and companies from all over Catalonia with the aim of promoting R+D+i in the field of printing 3D.

The groups led by Josep Samitier, Elisabeth Engel, Núria Montserrat and Javier Ramón at IBEC are joining the BASE3D project.

June 4, 2020January 15, 2020

Interviews with our experts

After a recent publication about “reprogrammable biological robots” in the PNAS magazine, several media wanted to know the opinion of Nuria Montserrat and Samuel Sánchez (both ICREA research professors and group leaders at IBEC) as experts in this field.

May 29, 2020October 31, 2019

IBEC recieves funding for three projects thanks to la Marató 2018

Three IBEC projects have been selected to receive funding from “La Marató 2018: Against Cancer.” One of the projects is led by the researcher Pere Roca-Cusachs and the other two are co-led by the researchers Xavier Trepat and Núria Montserrat.

The awarding ceremony took place on October 30 in the Auditorium of the Academy of Medical and Health Sciences of Catalonia and the Balearic Islands. In this edition, over the 188 evaluated projects, 43 have been selected by an international committee of experts in cancer based on their excellence, methodology and relevance. La Marató de TV3, together with Catalunya Ràdio, broadcasts its annual telethon to raise funds for scientific research into various diseases with a different theme each year.

June 4, 2020June 2, 2019

10 medical advances that will revolutionize the future

Nuria Montserrat and Pere Roca-Cusachs interviewed in the article “10 scientific advances that will revolutionize the future” of the newspaper Ara, talking about 3D tissue printing and mechanobiology.

May 29, 2020January 10, 2019

Two more juniors consolidate as full group leaders

Lorenzo Albertazzi and Nuria Montserrat, IBEC’s Junior Group Leaders selected in the 2014 Tenure Track programme, have been successfully consolidated as Group Leader as of 1st January 2019, following a positive evaluation by the ISC.

IBEC’s tenure track programme aims to support career development by helping young researchers establish their own independent research lines. Other factors considered included the added value offered by their projects to the current IBEC research programme, and the ability of the selected candidates to carry out efficient group leadership and management.

The first four junior group leaders selected by the programme in 2012 – Eduard Torrents, Elisabeth Engel, Pere Roca-Cusachs and Xavier Fernández-Busquets – were all successfully consolidated as Senior Group Leaders as of 1st January 2017.

June 4, 2020November 14, 2018

“Trasplantaments d’òrgans i teixits”

Yesterday Betevé’s Deuwatts programme featured IBEC’s Nuria Montserrat talking about organ regeneration.

June 9, 2020September 26, 2018

Two projects for IBEC at AECC ceremony

On Monday IBEC junior group leader Nuria Montserrat and senior researcher Aranzazu Villasante were two of the researchers awarded funding at the Asociación Española de Investigación sobre el Cáncer (AECC)’s ceremony in Madrid.

The AECC has bestowed 160 grants on cancer researchers during the past year, a total of €17.6m. The association made the official presentations of these awards at an event presided over by Her Majesty Queen Letizia on World Cancer Research Day, 24th September 2018.